Form 4: Pulmonx CFO Sells Shares for Tax Obligations
Insider Transaction Report
Pulmonx Corporation's Chief Financial Officer, Mehul Joshi, sold 7,936 shares of common stock to cover tax withholding obligations related to RSU vesting.
Summary
- Mehul Joshi, Chief Financial Officer and Principal Accounting Officer (PAO) of Pulmonx Corp, reported two sales of common stock.
- On September 2, 2025, 4,271 shares of common stock were sold at a price of $1.6 per share.
- On the same date, an additional 3,665 shares of common stock were sold, also at $1.6 per share.
- These sales were conducted to cover tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs) granted on May 6, 2024, and March 3, 2025.
- The transactions were made pursuant to a Rule 10b5-1(c) plan, indicating they were pre-scheduled.
- Following these reported transactions, Joshi beneficially owns 208,489 shares of Pulmonx common stock.
- The reported beneficial ownership includes 2,500 shares acquired by Joshi under the Issuer's 2020 Employee Stock Purchase Plan on August 15, 2025.
Sentiment
Score: 5
Explanation: The filing is a routine Form 4 disclosing insider sales for tax purposes, which is a neutral event. The transactions were pre-planned under a 10b5-1 plan, mitigating any negative sentiment typically associated with insider sales.
Future Outlook
NA
Industry Context
This Form 4 filing is a routine disclosure of insider stock transactions and does not provide information relevant to broader industry trends or the competitive landscape. It reflects standard compensation and tax management practices for executives.
Stakeholder Impact
- Shareholders: Minor, as these are routine tax-related sales by an executive, often pre-scheduled, and do not indicate a change in company fundamentals or executive confidence beyond standard compensation practices.
Key Dates
| Date | Description |
|---|---|
| 2024-05-06 | Grant date of Restricted Stock Units (RSUs) for which shares were sold to cover tax obligations. |
| 2025-03-03 | Grant date of Restricted Stock Units (RSUs) for which shares were sold to cover tax obligations. |
| 2025-08-15 | Date 2,500 shares were acquired by the Reporting Person under the Issuer's 2020 Employee Stock Purchase Plan. |
| 2025-09-02 | Transaction date for the sale of 4,271 shares and 3,665 shares of common stock. |
| 2025-09-03 | Signature date of the reporting person's attorney-in-fact. |
Recommendation
holdThis Form 4 filing details routine, pre-scheduled sales by the CFO to cover tax obligations related to RSU vesting. Such transactions are common and do not typically reflect a change in the executive's long-term view of the company or its fundamentals. The sales were executed under a 10b5-1 plan, further indicating a lack of new material information influencing the decision. Therefore, this filing alone does not provide a basis for a change in investment recommendation; a 'hold' stance is maintained pending further fundamental analysis.
Keywords
Pulmonx Corp, LUNG, Mehul Joshi, CFO, Insider Trading, Form 4, Stock Sale, RSU Vesting, Tax Withholding, Employee Stock Purchase Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.